| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.973 | 0.003 | 0.973 | Platelet aggregation inhibitor | 0.955 0.003 CID_15135972 0.957 0.003 CID_13218672 | ||
| 0.969 | 0.002 | 0.969 | Platelet activating factor antagonist | 0.944 0.002 CID_15135972 0.945 0.002 CID_13218672 | ||
| 0.948 | 0.003 | 0.948 | Anticonvulsant | 0.941 0.003 CID_15135972 0.806 0.004 CID_13218672 | ||
| 0.895 | 0.001 | 0.895 | Benzodiazepine agonist | 0.735 0.002 CID_15135972 0.693 0.002 CID_13218672 | ||
| 0.772 | 0.003 | 0.772 | GABA receptor agonist | 0.365 0.005 CID_15135972 0.623 0.003 CID_13218672 | ||
| 0.528 | 0.077 | 0.528 | Antiinflammatory | 0.49 0.092 CID_15135972 0.291 0.223 CID_13218672 | ||
| 0.321 | 0.003 | 0.321 | Bromodomain-containing protein 4 inhibitor | 0.267 0.004 CID_15135972 0.242 0.004 CID_13218672 | ||
| 0.339 | 0.068 | 0.354 | Antithrombotic | 0.354 0.063 CID_15135972 | CID_15135972 | |
| 0.254 | 0.005 | 0.254 | GABA A receptor antagonist | 0.047 0.046 CID_15135972 0.116 0.013 CID_13218672 | ||
| 0.244 | 0.005 | 0.244 | GABA receptor antagonist | 0.105 0.014 CID_13218672 | ||
| 0.227 | 0.003 | 0.227 | Bromodomain-containing protein 3 inhibitor | 0.202 0.003 CID_15135972 0.201 0.003 CID_13218672 | ||
| 0.161 | 0.009 | 0.167 | Interleukin 5 antagonist | 0.167 0.008 CID_15135972 0.145 0.012 CID_13218672 | CID_15135972 | |
| 0.302 | 0.153 | 0.302 | Transcription factor inhibitor | |||
| 0.149 | 0.009 | 0.149 | Alpha 2d adrenoreceptor antagonist | 0.135 0.014 CID_13218672 | ||
| 0.206 | 0.068 | 0.206 | Platelet adhesion inhibitor | 0.16 0.095 CID_15135972 | ||
| 0.145 | 0.01 | 0.145 | Bromodomain-containing protein 2 inhibitor | 0.116 0.025 CID_15135972 0.091 0.053 CID_13218672 | ||
| 0.146 | 0.011 | 0.146 | Purinergic P2 antagonist | |||
| 0.109 | 0.007 | 0.109 | Cholecystokinin A antagonist | 0.042 0.023 CID_15135972 | ||
| 0.25 | 0.154 | 0.25 | GABA C receptor rho-3 antagonist | |||
| 0.242 | 0.155 | 0.242 | Immunosuppressant | 0.216 0.18 CID_15135972 | ||
| 0.095 | 0.015 | 0.095 | Phosphodiesterase VII inhibitor | 0.067 0.038 CID_15135972 | ||
| 0.085 | 0.01 | 0.085 | Cholecystokinin antagonist | 0.037 0.031 CID_15135972 0.039 0.03 CID_13218672 | ||
| 0.153 | 0.086 | 0.153 | Protein kinase (CK1) gamma 3 inhibitor | |||
| 0.114 | 0.055 | 0.114 | Interleukin 2 antagonist | 0.102 0.085 CID_15135972 | ||
| 0.145 | 0.09 | 0.145 | Polo-like kinase-3 inhibitor | 0.144 0.091 CID_15135972 | ||
| 0.092 | 0.039 | 0.092 | Phosphodiesterase 11A inhibitor | |||
| 0.092 | 0.039 | 0.092 | Phosphodiesterase XI inhibitor | |||
| 0.07 | 0.018 | 0.07 | Thromboxane synthase inhibitor | 0.055 0.037 CID_15135972 | ||
| 0.106 | 0.058 | 0.106 | Gastric antisecretory | |||
| 0.062 | 0.019 | 0.062 | Phosphodiesterase 7A inhibitor | 0.049 0.041 CID_13218672 | ||
| 0.095 | 0.054 | 0.095 | Potassium channel activator | |||
| 0.078 | 0.038 | 0.078 | Selectin antagonist | 0.064 0.046 CID_13218672 | ||
| 0.049 | 0.009 | 0.049 | Purinergic P2T antagonist | |||
| 0.13 | 0.094 | 0.13 | MAP3K9 inhibitor | 0.127 0.1 CID_13218672 | ||
| 0.153 | 0.118 | 0.153 | Death-associated protein kinase 3 inhibitor | |||
| 0.054 | 0.028 | 0.054 | Purinergic P2X antagonist | |||
| 0.083 | 0.058 | 0.083 | GABA A receptor agonist | |||
| 0.043 | 0.019 | 0.043 | VCAM-1 antagonist | 0.039 0.028 CID_13218672 | ||
| 0.042 | 0.019 | 0.042 | VCAM antagonist | 0.039 0.028 CID_13218672 | ||
| 0.037 | 0.016 | 0.037 | Vasopressin 1A antagonist | 0.027 0.022 CID_15135972 | ||
| 0.034 | 0.021 | 0.034 | Vasopressin 1 antagonist | |||
| 0.058 | 0.051 | 0.058 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.035 | 0.031 | 0.035 | Antidiuretic hormone antagonist | |||
| 0.134 | 0.131 | 0.134 | Psychostimulant | |||
| 0.032 | 0.029 | 0.032 | Purinergic P2X7 antagonist | |||
| 0.05 | 0.048 | 0.05 | Phosphodiesterase II inhibitor | |||
| 0.09 | 0.149 | 0.152 | Cytidine deaminase inhibitor | 0.152 0.074 CID_13218672 | CID_13218672 | |
| 0.083 | 0.171 | 0.152 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.152 0.087 CID_13218672 | CID_13218672 | |
| 0.02 | 0.109 | 0.043 | Benzodiazepine receptor peripheral-type antagonist | 0.043 0.011 CID_13218672 | CID_13218672 | |
| 0.026 | 0.176 | 0.046 | Factor IXa inhibitor | 0.046 0.044 CID_15135972 | CID_15135972 | |
| 0.132 | 0.313 | 0.25 | Toll-Like receptor 7 agonist | 0.25 0.148 CID_15135972 | CID_15135972 | |
| 0.122 | 0.331 | 0.239 | Toll-Like receptor agonist | 0.239 0.158 CID_15135972 | CID_15135972 | |
| 0.113 | 0.34 | 0.41 | Antiobesity | 0.41 0.062 CID_15135972 | CID_15135972 | |
| 0.13 | 0.402 | 0.433 | Cyclophilin D inhibitor | 0.433 0.074 CID_15135972 | CID_15135972 | |
| 0.057 | 0.49 | 0.205 | Hypoglycemic | 0.205 0.107 CID_15135972 | CID_15135972 | |
| 0.019 | 0.57 | 0.203 | Hypolipemic | 0.203 0.091 CID_15135972 | CID_15135972 | |
| 0.058 | 0.889 | 0.248 | Calcium channel L-type activator | 0.248 0.207 CID_15135972 | CID_15135972 | |
| 0.005 | 0.88 | 0.083 | Aminoacyl-tRNA synthetase inhibitor | 0.083 0.071 CID_15135972 | CID_15135972 | |
| 0.002 | 0.948 | 0.03 | 1,3-Beta-glucan synthase inhibitor | 0.03 0.016 CID_13218672 | CID_13218672 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |